Advanced search
1 file | 409.70 KB Add to list

Clinical impact of additional cytogenetic aberrations, cKIT and RAS mutations, and treatment elements in pediatric t(8;21)-AML : results from an international retrospective study by the International Berlin-Frankfurt-Münster study group

(2015) JOURNAL OF CLINICAL ONCOLOGY. 33(36). p.4247-4258
Author
Organization
Keywords
ACUTE MYELOID-LEUKEMIA, HIGH-DOSE CYTARABINE, COOPERATIVE-STUDY-GROUP, PROGNOSTIC-SIGNIFICANCE, ONCOLOGY-GROUP, CHROMOSOMAL-ABNORMALITIES, TANDEM DUPLICATION, KIT MUTATIONS, C-KIT, AML

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 409.70 KB

Citation

Please use this url to cite or link to this publication:

MLA
Klein, Kim et al. “Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML : Results from an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.” JOURNAL OF CLINICAL ONCOLOGY 33.36 (2015): 4247–4258. Print.
APA
Klein, K., Kaspers, G., Harrison, C. J., Beverloo, H. B., Reedijk, A., Bongers, M., Cloos, J., et al. (2015). Clinical impact of additional cytogenetic aberrations, cKIT and RAS mutations, and treatment elements in pediatric t(8;21)-AML : results from an international retrospective study by the International Berlin-Frankfurt-Münster study group. JOURNAL OF CLINICAL ONCOLOGY, 33(36), 4247–4258.
Chicago author-date
Klein, Kim, Gertjan Kaspers, Christine J Harrison, H Berna Beverloo, Ardine Reedijk, Mathilda Bongers, Jacqueline Cloos, et al. 2015. “Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML : Results from an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.” Journal of Clinical Oncology 33 (36): 4247–4258.
Chicago author-date (all authors)
Klein, Kim, Gertjan Kaspers, Christine J Harrison, H Berna Beverloo, Ardine Reedijk, Mathilda Bongers, Jacqueline Cloos, Andrea Pession, Dirk Reinhardt, Martin Zimmerman, Ursula Creutzig, Michael Dworzak, Todd Alonzo, Donna Johnston, Betsy Hirsch, Michal Zapotocky, Barbara De Moerloose, Alcira Fynn, Vincent Lee, Takashi Taga, Akio Tawa, Anne Auvrignon, Bernward Zeller, Erik Forestier, Carmen Salgado, Walentyna Balwierz, Alexander Popa, Jeffrey Rubnitz, Susana Raimondi, and Brenda Gibson. 2015. “Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML : Results from an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.” Journal of Clinical Oncology 33 (36): 4247–4258.
Vancouver
1.
Klein K, Kaspers G, Harrison CJ, Beverloo HB, Reedijk A, Bongers M, et al. Clinical impact of additional cytogenetic aberrations, cKIT and RAS mutations, and treatment elements in pediatric t(8;21)-AML : results from an international retrospective study by the International Berlin-Frankfurt-Münster study group. JOURNAL OF CLINICAL ONCOLOGY. 2015;33(36):4247–58.
IEEE
[1]
K. Klein et al., “Clinical impact of additional cytogenetic aberrations, cKIT and RAS mutations, and treatment elements in pediatric t(8;21)-AML : results from an international retrospective study by the International Berlin-Frankfurt-Münster study group,” JOURNAL OF CLINICAL ONCOLOGY, vol. 33, no. 36, pp. 4247–4258, 2015.
@article{6991143,
  author       = {Klein, Kim and Kaspers, Gertjan and Harrison, Christine J and Beverloo, H Berna and Reedijk, Ardine and Bongers, Mathilda and Cloos, Jacqueline and Pession, Andrea and Reinhardt, Dirk and Zimmerman, Martin and Creutzig, Ursula and Dworzak, Michael and Alonzo, Todd and Johnston, Donna and Hirsch, Betsy and Zapotocky, Michal and De Moerloose, Barbara and Fynn, Alcira and Lee, Vincent and Taga, Takashi and Tawa, Akio and Auvrignon, Anne and Zeller, Bernward and Forestier, Erik and Salgado, Carmen and Balwierz, Walentyna and Popa, Alexander and Rubnitz, Jeffrey and Raimondi, Susana and Gibson, Brenda},
  issn         = {0732-183X},
  journal      = {JOURNAL OF CLINICAL ONCOLOGY},
  keywords     = {ACUTE MYELOID-LEUKEMIA,HIGH-DOSE CYTARABINE,COOPERATIVE-STUDY-GROUP,PROGNOSTIC-SIGNIFICANCE,ONCOLOGY-GROUP,CHROMOSOMAL-ABNORMALITIES,TANDEM DUPLICATION,KIT MUTATIONS,C-KIT,AML},
  language     = {eng},
  number       = {36},
  pages        = {4247--4258},
  title        = {Clinical impact of additional cytogenetic aberrations, cKIT and RAS mutations, and treatment elements in pediatric t(8;21)-AML : results from an international retrospective study by the International Berlin-Frankfurt-Münster study group},
  url          = {http://dx.doi.org/10.1200/JCO.2015.61.1947},
  volume       = {33},
  year         = {2015},
}

Altmetric
View in Altmetric
Web of Science
Times cited: